2019 annual financial data
UroGen Pharma 2019 Net margin
Direct answer
Net margin was -584,144.44%.
Operating income was -109,478,000 USD and net income was -105,146,000 USD.
Operating cash flow was -71,017,000 USD.
Get free UroGen Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 18,000 USD
- Operating income
- -109,478,000 USD
- Net income
- -105,146,000 USD
- Operating cash flow
- -71,017,000 USD